Manufacturer
Sumitomo Pharma
Pharmaceutical manufacturer based in Japan
Japan
- Products listed
- 14
- Molecules
- 6
- Therapy areas
- 4
Sumitomo Pharma is a pharmaceutical manufacturer based in Japan. MedsAcross lists 14 of its products across 6 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- Japan
- Indian manufacturer
- No
- Also listed as
- Sumitomo Pharma America, Inc, Sumitomo Pharma America, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Sumitomo Pharma products through licensed channels, with the documents your regulator needs.
Neurology
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Aptiom kitOral | Eslicarbazepine | US FDA | Available on request |
| Aptiom 200 mg tabletOral | Eslicarbazepine | US FDA | Available on request |
| Aptiom 400 mg tabletOral | Eslicarbazepine | US FDA | Available on request |
| Aptiom 600 mg tabletOral | Eslicarbazepine | US FDA | Available on request |
| Aptiom 800 mg tabletOral | Eslicarbazepine | US FDA | Available on request |
Psychiatry
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Latuda 120 mg tabletOral | Lurasidone | US FDA | Available on request |
| Latuda 20 mg tabletOral | Lurasidone | US FDA | Available on request |
| Latuda 40 mg tabletOral | Lurasidone | US FDA | Available on request |
| Latuda 60 mg tabletOral | Lurasidone | US FDA | Available on request |
| Latuda 80 mg tabletOral | Lurasidone | US FDA | Available on request |
Nephrology and urology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Gemtesa 75 mg tabletOral | Vibegron | US FDA | Available on request |
Oncology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Orgovyx 120 mg tabletOral | Relugolix | US FDA | Available on request |
Other products
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Myfembree 1 mg/0.5 mg/40 mg tabletOral | Estradiol, Norethindrone and Relugolix | US FDA | Available on request |
| Rethymic 22000 mm implantIntramuscular | Allogeneic thymocyte-depleted thymus tissue | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Sumitomo Pharma
Send a request for any of these products. We confirm the licensed source, documents and lead time.